BGS-2456

N/A

Report date: 2025/01/26 16:20:21
NME

Base Information

Drug NameBGS-2456
Drug Alias NameFLT3 inhibitors (BridGene Biosciences)BGS-2456
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridGene Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridGene Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A